P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound
- Author
- SPAHN-LANGGUTH, H1 ; BAKTIR, G2 ; RADSCHUWEIT, A1 ; OKYAR, A2 ; TERHAAG, B3 ; ADER, P1 ; HANAFY, A1 ; LANGGUTH, P4
[1] School of Pharmacy, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany
[2] Department of Pharmacology, University of Istanbul, Istanbul, Turkey
[3] Arzneimittelwerk Dresden, Radebeul, Sweden
[4] Astra Hässle AB, Mölndal, Sweden - Conference title
- Clinical pharmacology of P-glycoprotein and related transporters. Part I
- Conference name
- Official Satellite Symposium of the 2nd Congress of the European Association of Clinical Pharmacology and Therapeutics (EACPT): Clinical pharmacology of P-glycoprotein and related transporters (EACPT): Clinical pharmacology of P-glycoprotein and related transporters (Berlin 1997)
- Author (monograph)
- WOODCOCK, B. G (Editor)1 ; PREISS, R (Editor)2
European Association of Clinical Pharmacology and Therapeutics, Europe (Funder/Sponsor)
[1] Institute for Clinical Pharmacology, University Hospital, Frankfurt am Main, Germany
[2] Institute of Clinical Pharmacology, University of Leipzig, Germany - Source
International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 1, pp 16-24 ; ref : 26 ref
- ISSN
- 0946-1965
- Scientific domain
- Pharmacology drugs
- Publisher
- Dustri, München
- Publication country
- Germany
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Absorption Animal Antagoniste Aralkylamine Association médicamenteuse Cellule tumorale Côlon Distribution Glycoprotéine P In vitro In vivo Interaction médicamenteuse Lignée cellulaire établie Pharmacocinétique Rat Récepteur biologique Récepteur β-adrénergique Talinolol Transporteur Tube digestif Tumeur maligne Voie intraveineuse Voie orale Vérapamil Appareil digestif pathologie Côlon pathologie Intestin pathologie Mammalia Rodentia Vertebrata
- Keyword (en)
- Absorption Animal Antagonist Aralkylamine Drug combination Tumor cell Colon Distribution P Glycoprotein In vitro In vivo Drug interaction Established cell line Pharmacokinetics Rat Biological receptor β-Adrenergic receptor Talinolol Conveyor Digestive tract Malignant tumor Intravenous administration Oral administration Verapamil Digestive diseases Colonic disease Intestinal disease Mammalia Rodentia Vertebrata
- Keyword (es)
- Absorción Animal Antagonista Aralquilamina Asociación medicamentosa Célula tumoral Colón Distribución Glycoproteina P In vitro In vivo Interacción medicamentosa Línea celular establecida Farmacocinética Rata Receptor biológico Receptor β-adrenérgico Talinolol Transportador Tubo digestivo Tumor maligno Vía intravenosa Vía oral Verapamilo Aparato digestivo patología Colón patología Intestino patología Mammalia Rodentia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A04 Molecular and cellular biology / 002A04H Cell physiology / 002A04H06 Membrane and intracellular transports
- Discipline
- Molecular and cell biology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2145818
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:9:\"\u0000*\u0000jtitle\";s:63:\"International journal of clinical pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:29:\"Int. j. clin. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"24\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-1965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SPAHN-LANGGUTH\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"BAKTIR, G\";i:1;s:14:\"RADSCHUWEIT, A\";i:2;s:8:\"OKYAR, A\";i:3;s:10:\"TERHAAG, B\";i:4;s:7:\"ADER, P\";i:5;s:9:\"HANAFY, A\";i:6;s:11:\"LANGGUTH, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:72:\"Clinical pharmacology of P-glycoprotein and related transporters. Part I\";s:8:\"\u0000*\u0000title\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:8:\"\u0000*\u0000place\";s:8:\"M\u00fcnchen\";s:6:\"\u0000*\u0000pub\";s:6:\"Dustri\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:9:\"\u0000*\u0000jtitle\";s:63:\"International journal of clinical pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:29:\"Int. j. clin. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"24\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-1965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SPAHN-LANGGUTH\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"BAKTIR, G\";i:1;s:14:\"RADSCHUWEIT, A\";i:2;s:8:\"OKYAR, A\";i:3;s:10:\"TERHAAG, B\";i:4;s:7:\"ADER, P\";i:5;s:9:\"HANAFY, A\";i:6;s:11:\"LANGGUTH, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:72:\"Clinical pharmacology of P-glycoprotein and related transporters. Part I\";s:8:\"\u0000*\u0000title\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:8:\"\u0000*\u0000place\";s:8:\"M\u00fcnchen\";s:6:\"\u0000*\u0000pub\";s:6:\"Dustri\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:9:\"\u0000*\u0000jtitle\";s:63:\"International journal of clinical pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:29:\"Int. j. clin. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"24\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-1965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SPAHN-LANGGUTH\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"BAKTIR, G\";i:1;s:14:\"RADSCHUWEIT, A\";i:2;s:8:\"OKYAR, A\";i:3;s:10:\"TERHAAG, B\";i:4;s:7:\"ADER, P\";i:5;s:9:\"HANAFY, A\";i:6;s:11:\"LANGGUTH, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:72:\"Clinical pharmacology of P-glycoprotein and related transporters. Part I\";s:8:\"\u0000*\u0000title\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:8:\"\u0000*\u0000place\";s:8:\"M\u00fcnchen\";s:6:\"\u0000*\u0000pub\";s:6:\"Dustri\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:9:\"\u0000*\u0000jtitle\";s:63:\"International journal of clinical pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:29:\"Int. j. clin. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"24\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-1965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SPAHN-LANGGUTH\";s:10:\"\u0000*\u0000aufirst\";s:1:\"H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"BAKTIR, G\";i:1;s:14:\"RADSCHUWEIT, A\";i:2;s:8:\"OKYAR, A\";i:3;s:10:\"TERHAAG, B\";i:4;s:7:\"ADER, P\";i:5;s:9:\"HANAFY, A\";i:6;s:11:\"LANGGUTH, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:72:\"Clinical pharmacology of P-glycoprotein and related transporters. Part I\";s:8:\"\u0000*\u0000title\";s:161:\"P-glycoprotein transporters and the gastrointestinal tract : Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound\";s:8:\"\u0000*\u0000place\";s:8:\"M\u00fcnchen\";s:6:\"\u0000*\u0000pub\";s:6:\"Dustri\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
